+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Multicenter, open-label study of the long-term safety and efficacy of RAD used in combination with Simulect , corticosteroids and Neoral in renal transplantation 6 Month results



Multicenter, open-label study of the long-term safety and efficacy of RAD used in combination with Simulect , corticosteroids and Neoral in renal transplantation 6 Month results



Journal of the American Society of Nephrology 11(Program and Abstract Issue): 685A




(PDF emailed within 1 workday: $29.90)

Accession: 035349976

Download citation: RISBibTeXText


Related references

Open-label, multicenter study on the safety, tolerability, and efficacy of Simulect in pediatric renal transplant recipients receiving triple therapy with cyclosporin, mycophenolate, and corticosteroids. Transplantation Proceedings 37(2): 672-674, 2005

Long-term safety of abobotulinumtoxinA for the treatment of glabellar lines: results from a 36-month, multicenter, open-label extension study. Dermatologic Surgery 40(2): 176-183, 2014

Efficacy and safety of enteric-coated mycophenolate sodium (myfortic) in de novo renal transplant recipients: results of a 12-month multicenter, open-label, prospective study. Transplantation Proceedings 38(5): 1301-1306, 2006

A 12-month, multicenter, randomized, adaptive design, open-label study to evaluate the benefit of C2 hour monitoring of neoral on safety and efficacy outcomes in de novo cardiac transplant recipients receiving basiliximab induction. Journal of Heart & Lung Transplantation 23(2S): S107, 2004

Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: results from a 52-week, open-label, multicenter extension study. Dementia and Geriatric Cognitive Disorders 36(3-4): 229-241, 2014

Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan. Dementia and Geriatric Cognitive Disorders 27(3): 232-239, 2009

A multicenter, open-label, pharmacokinetic/pharmacodynamic safety, and tolerability study of basiliximab (Simulect) in pediatric de novo renal transplant recipients. Transplantation 74(7): 961-966, 2002

Results of a 6-month, multicenter, open-label, prospective study concerning efficacy and safety of mycophenolate sodium in de novo kidney transplant recipients. Transplantation Proceedings 39(9): 2730-2732, 2007

Long-term safety and efficacy of armodafinil in bipolar depression: A 6-month open-label extension study. Journal of Affective Disorders 197: 51-57, 2016

Efficacy and safety of OM-8980 in patients with rheumatoid arthritis: An open-label, long-term, multicenter study. Current Therapeutic Research 60(12): 638-649, 1999

Long-term safety and efficacy of cabergoline for the treatment of idiopathic restless legs syndrome: results from an open-label 6-month clinical trial. Sleep 27(4): 674-682, 2004

A 6-month, open-label, multicenter clinical study in Korean de novo renal transplant patients evaluating the efficacy, safety, and tolerance of myfortic concomitantly used with tacrolimus. Transplantation Proceedings 44(1): 144-146, 2012

Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan. Epilepsy Research 113: 90-97, 2016

Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study. Journal of the American Society of Hypertension 8(12): 915-920, 2015

Open-label infliximab therapy in Crohn's disease: a long-term multicenter study of efficacy, safety and predictors of response. Gastroenterologia Y Hepatologia 31(7): 421-426, 2008